1.4.2.4 Russia Market States and Outlook ( 2012-2022 ) 1.4.2.5 Italy Market States and Outlook ( 2012-2022 ) 1.4.3 Asia-Pacific ( China , Japan , Korea , India and Southeast Asia ) 1.4.3.1 China Market States and Outlook ( 2012-2022 ) 1.4.3.2 Japan Market States and Outlook ( 2012-2022 ) 1.4.3.3 Korea Market States and Outlook ( 2012-2022 ) 1.4.3.4 India Market States and Outlook ( 2012-2022 ) 1.4.3.5 Southeast Asia Market States and Outlook ( 2012-2022 ) 1.4.4 South America , Middle East and Africa 1.4.4.1 Brazil Market States and Outlook ( 2012-2022 ) 1.4.4.2 Egypt Market States and Outlook ( 2012-2022 ) 1.4.4.3 Saudi Arabia Market States and Outlook ( 2012-2022 ) 1.4.4.4 South Africa Market States and Outlook ( 2012-2022 ) 1.4.4.5 Nigeria Market States and Outlook ( 2012-2022 ) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Johnson & Johnson 2.1.1 Business Overview 2.1.2 Onychomycosis ( Tinea Unguium ) Drug Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 Johnson & Johnson Onychomycosis ( Tinea Unguium ) Drug Sales , Price , Revenue , Gross Margin and Market Share ( 2016-2017 ) 2.2 GSK 2.2.1 Business Overview 2.2.2 Onychomycosis ( Tinea Unguium ) Drug Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 GSK Onychomycosis ( Tinea Unguium ) Drug Sales , Price , Revenue , Gross Margin and Market Share ( 2016-2017 ) 2.3 Novartis 2.3.1 Business Overview 2.3.2 Onychomycosis ( Tinea Unguium ) Drug Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 Novartis Onychomycosis ( Tinea Unguium ) Drug Sales , Price , Revenue , Gross Margin and Market Share ( 2016-2017 ) 2.4 Pfizer 2.4.1 Business Overview 2.4.2 Onychomycosis ( Tinea Unguium ) Drug Type and Applications 2.4.2.1 Type 1 2.4.2.2 Type 2 2.4.3 Pfizer Onychomycosis ( Tinea Unguium ) Drug Sales , Price , Revenue , Gross Margin and Market Share ( 2016-2017 ) 2.5 Valeant Pharma 2.5.1 Business Overview 2.5.2 Onychomycosis ( Tinea Unguium ) Drug Type and Applications